Medicine & Life Sciences
Diazoxide
100%
Non-alcoholic Fatty Liver Disease
78%
Fatty Liver
77%
Hypothyroidism
74%
Hypophysitis
74%
Hypoglycemia
70%
Chronic Kidney Failure
64%
Immunotherapy
64%
Liver Diseases
61%
Insulin
57%
Type 2 Diabetes Mellitus
54%
Thyroid Function Tests
48%
Odds Ratio
46%
Thyroxine
46%
SARS Virus
35%
Sodium-Glucose Transporter 2 Inhibitors
35%
Dipeptidyl-Peptidase IV Inhibitors
32%
Liver
31%
Weight Loss
30%
Gluconeogenesis
29%
Inpatients
29%
Outpatients
27%
Bariatric Surgery
27%
Therapeutics
26%
Kidney
26%
Mortality
24%
Antihypertensive Agents
22%
Renal Insufficiency
21%
Weights and Measures
21%
Pancreas
20%
Hemoglobins
19%
Adenosine Triphosphate
18%
Hospitalization
17%
Thiazolidinediones
15%
Incretins
15%
Glucagon-Like Peptide-1 Receptor
15%
Investigational Therapies
14%
Noncommunicable Diseases
14%
Metformin
13%
Expert Testimony
12%
Insurance
12%
Hyperlipidemias
12%
Infections
11%
Chronic Renal Insufficiency
11%
Weight Gain
11%
Edema
9%
PubMed
9%
Body Mass Index
8%